Provided by Tiger Fintech (Singapore) Pte. Ltd.

bluebird bio

4.30
+0.400010.26%
Volume:99.03K
Turnover:409.87K
Market Cap:42.10M
PE:-0.17
High:4.32
Open:3.90
Low:3.90
Close:3.90
Loading ...

bluebird bio Inc Shares Gain Ground After the Bell Following Confirmation It Received Unsolicited Proposal, Last up 13% at Around $4.60

THOMSON REUTERS
·
29 Mar

Bluebird Bio confirms receipt non-binding proposal from Ayrmid

TIPRANKS
·
29 Mar

bluebird bio Inc - Board Reviewing Ayrmid Proposal With Advisors

THOMSON REUTERS
·
29 Mar

bluebird bio Inc - Ayrmid Did Not Submit Any Proposal to Bluebird as Part of Its Review of Strategic Alternatives

THOMSON REUTERS
·
29 Mar

bluebird bio Inc - Not Changed Its Recommendation in Support of Carlyle and SK Capital Partners Deal

THOMSON REUTERS
·
29 Mar

bluebird bio Confirms Receipt of an Unsolicited Non-Binding Proposal From Ayrmid

THOMSON REUTERS
·
29 Mar

Press Release: bluebird bio Confirms Receipt of an Unsolicited Non-Binding Proposal from Ayrmid

Dow Jones
·
29 Mar

bluebird bio Shares Climb Sharply to Session High With Volume Spike, Last up Around 11% at $4.22 After Touching $4.43

THOMSON REUTERS
·
29 Mar

bluebird bio Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Mar

Bluebird Bio (BLUE) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
28 Mar

Press Release: BLUE ANT MEDIA ANNOUNCES GO PUBLIC TRANSACTION BY WAY OF REVERSE TAKEOVER OF BOAT ROCKER MEDIA

Dow Jones
·
24 Mar

bluebird bio Inc expected to post a loss of $6.15 a share - Earnings Preview

Reuters
·
21 Mar

Biotech Stock Roundup: BLUE Down on Update, News From GILD, TRDA

Zacks
·
26 Feb

JPMorgan Upgrades bluebird bio to Neutral From Underweight

MT Newswires Live
·
24 Feb

bluebird bio Raised to Neutral From Underweight by JP Morgan

Dow Jones
·
24 Feb

BUZZ-J.P. Morgan upgrades bluebird bio to 'neutral'

Reuters
·
24 Feb

U.S. RESEARCH ROUNDUP-Amneal pharma, Aramark, Bluebird Bio

Reuters
·
24 Feb

bluebird bio Inc : JP Morgan Raises to Neutral From Underweight

THOMSON REUTERS
·
24 Feb

BofA moves to No Rating on Bluebird Bio after deal announcement

TIPRANKS
·
22 Feb

Top Midday Decliners

MT Newswires Live
·
22 Feb